As of Q4'25 (2025-12-31), RXRX reported a diluted EPS of -0.21 USD, marking a significant improvement compared to previous quarters. The year-over-year EPS growth for this period reached 63.16%, indicating a strong positive turnaround. From Q1'23 to Q4'25, RXRX's diluted EPS showed a generally negative trend, with values fluctuating between -0.34 USD and a low of -0.57 USD in Q4'24. However, the data reveals notable volatility, with periods of further decline followed by gradual recovery, culminating in a sharp improvement in Q4'25. The YoY EPS growth line highlights this volatility, with several quarters of negative growth interspersed with positive spikes, most notably in Q3'24 (20.93%) and Q4'25 (63.16%), suggesting the company may be moving toward improved earnings performance.